¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gamma heavy chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Caroli disease
    Ä«·Ñ¸®º´
  • cat-scratch disease
    °í¾çÀÌÇÒÅ¡º´
  • celiac disease
    º¹°­º´, º¹°­Áúȯ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • central core disease
    Áß½ÉÇÙº´, Áß½ÉÄھ
  • caloric disease
    °í¿Âº´
  • cerebrovascular disease
    ³úÇ÷°üÁúȯ, ³úÇ÷°üº´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´
  • Canavan disease
    ij³Ê¹øº´
  • cholesteryl ester storage disease
    ÄÝ·¹½ºÅ×·Ñ¿¡½ºÅ׸£ÃàÀûº´
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • deficiency disease
    °áÇ̺´
  • degenerative disease
    ÅðÇິ, º¯¼ºº´
  • degenerative joint disease
    ÅðÇà°üÀýº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • disease
    º´
  • deficiency disease
    ¿µ¾ç°áÇ̺´
  • degenerative disease
    ÅðÇິ
  • degenerative joint disease
    (¢¡osteoarthritis) »À°üÀý¿°, °ñ°üÀý¿°
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • detergent worker¡¯s disease
    ¼¼Á¤Á¦Ãë±ÞÀÚº´
  • developmental disease
    ¹ß´ÞÀå¾Ö
  • diarrheal disease
    ¼³»çº´
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
  • diffuse interstitial pulmonary disease
    ±¤¹üÀ§»çÀÌÁúÆóº´, ¹Ì¸¸°£ÁúÆóº´
  • digestive tract disease
    ¼ÒÈ­°üº´
  • disease detection
    Áúº´¹ß°ß
  • disease entity
    Áúº´´ÜÀ§, Áúº´¸í
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Creutzfeld-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄߺ´.
  • Creutzfeldt-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄß º´
  • Creutzfeldt-Jakob disease(CJD)
    Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
  • Crohns disease
    Å©·Ðº´
  • Crohns disease
    Å©·Ðº´.
  • Crouzons disease =craniofacial dysostosis
    µÎ°³¾È¸éȸ°ñºÎÀüÁõ, Å©·ç Á¾º´ µÎ°³¾È¸éÀ̰ñÁõ .
  • Cushings disease
    Äí½Ìº´.
  • Dariers disease => keratosis follicularis
    ´Ù¸®¿¡ º´
  • Degenerative disease
    ÅðÇ༺Áúȯ
  • Dego s disease
    µ¥°íº´.
  • Dejerine-Sottas disease
    µ¥Á¦¸°-¼ÚŸº´.
  • Dercums disease
    ´õÄĺ´
  • Detergent workers disease
    ¼¼Á¤Á¦Ãë±ÞÀÚÁúȯ
  • Devics disease=>optic neuromyelitis
    µ¥ºòº´
  • Di Guglielmos disease
    µð±¸±Û¸®¿¤¸ðº´, ÀûÇ÷º´¼º °ñ¼öÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • respiratory chain
    È£Èí»ç½½.
  • reverberating chain
    ¹ÝÇâ(ÚãúÂ)»ç½½.
  • side chain
    Ãø¼â, °ç°¡Áö, °ç»ç½½.
  • side chain isomerism
    Ãø¼âÀ̼º(ö°áðì¶àõ).
  • side chain theory
    Ç×ü»ý»êÃø¼â¼³
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ.
  • sympathetic chain
    ±³°¨½Å°æ»ç½½
  • sympathetic ganglion chain
    ±³°¨½Å°æÀý¿¬¼â(¡­ææáð).
  • blood disease =hemic disease
    Ç÷¾×Áúȯ(Ì´Ëâ̷̤).
  • blood disease =hemic disease
    Ç÷¾×Áúȯ(úìäûòðü´).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • side chain cleavage
    °ç°¡Áö Àý´Ü(ï·Ó¨)
  • side chain theory
    °ç°¡Áö ÀÌ·Ð(×âÖå)
  • straight chain
    °ðÀº »ç½½
  • triple-chain length
    »ï(ß²)»ç½½ ±æÀÌ
  • two-genes-one-polypeptide chain
    ÀÌÀ¯ÀüÀÚ(ì£ë¶îîí­)- ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
Gm an allotype marker on the heavy chains of immunoglobins
HMM heavy meromyosin; hexamethyl-melamine
HS Haber syndrome; half strength; hamstring; hand surgery; Hartmann solution; head sling; healthy subje...
NEFH heavy polypeptide of neurofilament protein
NFH heavy polypeptide of neurofilament protein; nonfamilial hematuria
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
r-IFN-gamma Recombinant gamma interferon
rIFN-gamma Recombinant human interferon gamma
rhIFN-gamma Recombinant human interferon-gamma
rIFN-gamma Recombinant interferon gamma
TCR gamma T cell receptor gamma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • double vessel disease
    ÀÌÁß °ü»ó µ¿¸Æ Áúȯ
  • Ebstein anomaly disease
    ¿¦½ºÅ¸ÀÎ º´
    ¿ì½É½Ç°ú ¿ì½É¹æ »çÀÌ¿¡ ÀÖ´Â »ï÷ÆÇ
  • epizootic hemorrhagic disease
    °¡Ãà À¯Ç༺ ÃâÇ÷¼º Áúȯ
  • F1 hybrid disease
    F1 ÇÏÀ̺긮µå Áúȯ
    ÇÑÂÊ ¾î¹öÀÌÀÇ ¸é¿ª ´ã´ç ¼¼Æ÷¸¦ F
  • Fabry Anderson disease
    ÆÐºê¸® ¾Ø´õ½¼ Áúȯ
  • febrile disease
    ¿­¼º Áúȯ
  • fifth disease
    Á¦ 5º´
  • flat Bowen's disease
    ÆíÆò Bowen Áúȯ
  • focal disease
    ÃÊÁ¡¼º Áúȯ
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • Fordyce's disease
    Æ÷¿À´ÙÀ̽º º´
  • Hailey-Hailey disease
    ÇìÀϸ® ÇìÀϸ® º´
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â. °æºÎ, ¾×¿Í, ¼­ÇýºÎ¿¡ ÀÛÀº ¼öÆ÷ ¹× Å« ¼öÆ÷°¡ ¹Ýº¹ÇÏ¿© ¹ß»ýÇÏ´Â Èñ±ÍÇÑ À¯Àü¼º Áúȯ. »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ¸ç ºÒ¿ÏÀüÇÑ Ç¥ÇöÀ²À» °¡Áø´Ù. ¸ð³¶ °¢È­Áõ°ú À¯»çÇÏ°Ô »ý°¢ÇÏ¸ç ºÎÂø ¹Ý³» ¼¼Æ÷°£ Á¢ÃËÃþÀÇ ¼Ò½Ç ¶Ç´Â ´ç±è¼¼»çÀÇ °áÇÔÀ» µé°í ÀÖ´Ù.
  • hand and foot disease
    ¼Õ¹ß º´, ¼öÁ· º´
  • hand foot and mouth disease
    ¼öÁ·±¸ º´, ¼Õ¹ßÀÔ º´, ¼Õ¹ß ¹× ±¸°­ Áúȯ, ¼Õ-¹ß-±¸°­ Áúȯ
    1. ÄÛ»çŰ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ »ý±ä µå¹® Àå ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. 2. °æÁõÀ̳ª ´ë´ÜÈ÷ °¨¿°·ÂÀÌ ÀÖ´Â ¼Ò¾ÆÀÇ ¹ÙÀÌ·¯½º º´À¸·Î¼­, ÀÔ, ¼öÁ·¿¡ ¼öÆ÷¼º º´º¯À» º¼ ¼ö ÀÖ´Â °ÍÀÌ ±× Ư¡ÀÌ´Ù. 3. ÄÛ»çŰ ¹ÙÀÌ·¯½º A16ÀÇ °¨¿°À¸·Î ¼Õ, ¹ß, ÇÏÁö, ÀÔ¼Ó¿¡ ÀÛÀº ¼öÆ÷°¡ »ý±â´Â Áúº´. ÁÖ·Î Á¥¸ÔÀÌ¿¡°Ô Àß ³ªÅ¸³ª´Â °¨¿°ÁõÀε¥, 6°³¿ù ¹Ì¸¸ÀÇ Á¥¸ÔÀÌ¿Í 4¼¼ ÀÌ»óÀÇ ¾î¸°ÀÌ¿¡°Ô´Â µå¹°°Ô °¨¿°µÈ´Ù. ³²ÀÚ ¾î¸°ÀÌ¿¡°Ô ¸¹°í ¼ºÀο¡°Ôµµ ³ªÅ¸³­´Ù. ¿©¸§Ã¶¿¡ ÁÖ·Î ¹ßº´Çϰí 4~6Àϰ£ÀÇ Àẹ±â¸¦ °ÅÄ£´Ù. Áõ¼¼´Â ´ëü·Î °¡º±´Ù. 1957³â ij³ª´Ù Åä·ÐÅä¿¡¼­ À¯ÇàÇßÀ» ¶§ ·Îºó½¼ µîÀÌ ÀÌ Áõ¼¼¿¡ ´ëÇØ ±â·ÏÇß°í, ´º¿åÁÖ ÄÛ»çŰ¿¡¼­ óÀ½À¸·Î ÀÌ ¹ÙÀÌ·¯½º¸¦ ºÐ¸®½ÃŲ µ¥¼­ ±× Áö¹æ¸íÀ» µû¼­ ¸í¸íÇÏ¿´´Ù. ±× ´ç½Ã º´¿øÃ¼´Â ÄÛ»çŰ A16 ¹ÙÀÌ·¯½º¿´À¸³ª, ÈÄ¿¡ ÄÛ»çŰ A5, A10°ú ¿£Å×·Î ¹ÙÀÌ·¯½º 71Çü¿¡ ÀÇÇØ¼­µµ °°Àº Áõ¼¼ÀÇ º´ÀÌ ³ªÅ¸³­´Ù´Â °ÍÀÌ ¹àÇôÁ³´Ù. ÁÖ·Î ºñ¸» °¨¿°, °æ±¸ °¨¿°À¸·Î Àü¿°µÈ´Ù.
  • Hand Schuller Christian disease
    ÇÑÆ® ½¶·¯ Å©¸®½ºÂù º´, ÇÚµå ½¶·¯ Å©¸®½ºÂù º´, Hand-Schuller-Christian º´
    1. ´Ù¼Ò¼º È£»ê¼º À°¾ÆÁ¾ÀÌ 5¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â °æ¿ì¿¡ »ç¿ëÇÏ´Â ¿ë¾î. ¹ß¿­, Àü½Å¼º Àμ³, µÎÇÇ¿Í À̰ü ÇǺÎÀÇ Áö·ç¼º ¹ßÁø, ÁßÀÌ¿°, À¯¾çµ¹±â¿° ¹× Ä¡Àº¿°°ú »ó±âµµ ¿°ÁõÀ» ÈçÈ÷ µ¿¹ÝÇÑ´Ù. 2. °æµµÀÇ ¸²ÇÁÀý Á¾´ë, °£ºñ Á¾´ë°¡ ÃÊ·¡µÉ ¼ö ÀÖ°í ÆóÀå³»¿¡ À°¾ÆÁ¾ Çü¼º ¶Ç´Â °£ÇæÀûÀÎ ¹Ì»ý¹° °¨¿°¿¡ ÀÇÇÑ °ÍÀ¸·Î º¸ÀÌ´Â ¹Ì¸¸¼º Æó¿° ¼Ò°ßÀ» º¼ ¼ö ÀÖ´Ù. 3. ¾î¸°ÀÌ ¹× 10´ë Ãʹݿ¡ ¹ßº´Çϸç 3´ë Áõ»óÀ¸·Î´Â ¾È±¸ µ¹ÃâÁõ, °ñ º´¼Ò, ´¢ºØÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
P light chain <protein> Myosin light chain that can be phosphorylated by myosin light chain kinase, as a result of phosphorylation, the myosin is activated.
(18 Nov 1997)
corticosteroid side-chain-isomerase <enzyme> Converts 11-deoxycorticosterone to 20-hydroxy-3-oxypregn-4-en-21-al; also acts as an epimerase at c-20
Registry number: EC 5.3.1.21
Synonym: corticosteroid side chain isomerase, ccsci
(26 Jun 1999)
polymerase chain reaction <molecular biology, technique> The first practical system for in vitro amplification of DNA and as such one of the most important recent developments in molecular biology.
Two synthetic oligonucleotide primers, which are complementary to two regions of the target DNA (one for each strand) to be amplified, are added to the target DNA (that need not be pure), in the presence of excess deoxynucleotides and Taq polymerase, a heat stable DNA polymerase. In a series (typically 30) of temperature cycles, the target DNA is repeatedly denatured (around 90_C), annealed to the primers (typically at 50-60_C) and a daughter strand extended from the primers (72_C). As the daughter strands themselves act as templates for subsequent cycles, DNA fragments matching both primers are amplified exponentially, rather than linearly.
The original DNA need thus be neither pure nor abundant and the polymerase chain reaction has accordingly become widely used not only in research, but in clinical diagnostics and forensic science.
Acronym: PCR
(14 Oct 1997)
myosin light chain <protein> The light chains of the muscle protein myosin. Each molecule of myosin is composed of two heavy chains and two pairs of light chains. The light chains have a molecular weight of about 20 kD and there is one dissimilar pair of light chains associated with each heavy chain.
The proteins all have sequence homology to calmodulin, but not all with calcium binding activity.
Several types are known: regulatory light chains (LC 2, DNTB light chains) probably regulate the ATPase activity of the heavy chain directly (through the binding of calcium) or indirectly (activating when they themselves are phosphorylated by myosin light chain kinase) and essential light chains (LC 1, LC 3, alkali light chains), which have a more subtle and apparently nonessential role.
In molluscan muscle the EDTA light chains (similar to LC 2 from vertebrate muscle) confer calcium sensitivity on the myosin itself.
The light chains are "calmodulin-like" proteins that bind calcium. Two of them can be removed easily, and two with difficulty. The light chains bind the heavy chains in the vicinity of the head groups of the myosin.
(12 Dec 1998)
myosin light chain kinase <enzyme> An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin.
The 20-kD light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.
Chemical name: ATP:myosin-light-chain O-phosphotransferase
Registry number: EC 2.7.1.117
(12 Dec 1998)
haemolytic chain The haemolysis that occurs when complement is activated by the previously formed union of erythrocytes and specific antibody.
(05 Mar 2000)
H chain <protein> Heavy chain of immunoglobulin, see IgG, IgM, etc.
(18 Nov 1997)
xenobiotic medium chain fatty acid - coenzyme A ligase <enzyme> Partial amino acid sequence of enzyme from bovine liver mitochondria given I first source; has high sequence homology to human and rat sa protein
Registry number: EC 6.2.1.-
Synonym: xl-i ligase, xl-i carboxylic acid - CoA ligase
(26 Jun 1999)
short chain In bacteriology, a string of two to eight cells.
(05 Mar 2000)
short-chain acyl-CoA dehydrogenase See: acyl-CoA dehydrogenase (NADPH+).
(05 Mar 2000)
short-chain beta-hydroxyacyl-CoA dehydrase <enzyme> Forms trans-2-enoyl-CoA; maximal activity with trans-2-hexenoyl-CoA, followed by crotonyl-CoA; not the same as EC 4.2.1.17
Registry number: EC 4.2.1.-
Synonym: beta-hydroxybutyryl-CoA dehydrase, short-chain beta-hydroxyacyl-coenzyme a dehydrase
(26 Jun 1999)
side chain A chain of noncyclic atoms linked to a benzene ring, or to any cyclic chain compound, the atoms of an alpha-amino acid other than the alpha-carboxyl group, the alpha-amino group, the alpha-carbon, and the hydrogen attached to the alpha-carbon.
(05 Mar 2000)
side-chain theory Ehrlich postulated that cells contained surface extensions or side chains (haptophores) that bind to the antigenic determinants of a toxin (toxophores); after a cell is stimulated, the haptophores are released into the circulation and become the antibodies.
See: receptor.
Synonym: Ehrlich's postulate.
(05 Mar 2000)
nuclear chain fibre The shortest and most numerous type of intrafusal muscle fibre's in a neuromuscular spindle, containing a single row of centrally positioned nuclei.
(05 Mar 2000)
delta chain See: immunoglobulin. The heavy chains of mouse and human IgD immunoglobulins.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • occupational disease
    Á÷¾÷º´
  • parkinsons disease
    ÁøÀü ¸¶ºñ
  • pind disease
    Áö´Üµ¿ÅëÁõ(À¯¾Æº´)
  • pink disease
    Áö´Üµ¿Åë
  • pompe's disease
    ÆûÆäº´
  • potts disease
    Æ÷Æ®º´;ôÃß Ä«¸®¿¡½º
  • psychosomatic disease
    Á¤½Å ½Åü (½É½Å) Áõ
  • pullet disease
    X;=BLUE COMB
  • rat-bite fever(disease)
    ¼­±³¿­
  • rheumatic disease
    ·ù¸ÓƼ½º¼º Áúȯ
  • social disease
    ¼ºº´
  • stress disease
    (ÀÚ±Ø,±äÀåÀ¸·Î ÀϾ´Ù´Â) ½ºÆ®·¹½ºº´
  • vocational disease
    Á÷¾÷º´
  • zymotic disease
    ¹ßÈ¿º´;¹ßÈ¿°¡ º´ÀÎÀ¸·Î ¿©°ÜÁ³´øsmallpoxµûÀ§
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á